Centre of Research Excellence in Redefining
Antimicrobial Use to Reduce Resistance CRE REDUCE
Site search

BLING III: A phase III randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients

    Funding source: 
    National Health and Medical Research Council

    Project members

    Professor Jeffrey Lipman

    Professor Jason Roberts

    CRE Director

    Professor Jean-Yves Lefrant

    Professor John Myburgh

    Professor David Paterson

    Professor Jan De Waele